Symbiox Investment & Trading Co Ltd
NSE: BSE: 539278
₹1.62
(-5.81%)
Wed, 18 Mar 2026, 02:41 pm
Market Cap0
PE Ratio0
Dividend0
Finance
Investment Banks/Brokers
24.5KSymbiox Investment & Trading Co Analysis
dividend
- Unable to evaluate Symbiox Investment & Trading Co's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Symbiox Investment & Trading Co's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Symbiox Investment & Trading Co is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Symbiox Investment & Trading Co has been profitable on average in the past, therefore cash runway is not a concern.
- Symbiox Investment & Trading Co has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (607.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 121.5x debt.
- Symbiox Investment & Trading Co's cash and other short term assets cover its long term commitments.
- Symbiox Investment & Trading Co's level of debt (0.8%) compared to net worth is satisfactory (less than 40%).
- Low level of unsold assets.
management
- The average tenure for the Symbiox Investment & Trading Co board of directors is less than 3 years, this suggests a new board.
misc
- Symbiox Investment & Trading Co is not covered by any analysts.
- Symbiox Investment & Trading Co has significant price volatility in the past 3 months.
past
- Unable to compare Symbiox Investment & Trading Co's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Symbiox Investment & Trading Co does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Symbiox Investment & Trading Co has efficiently used its assets last year compared to the IN Retail Distributors industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Symbiox Investment & Trading Co improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Symbiox Investment & Trading Co has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Symbiox Investment & Trading Co's 1-year growth to the IN Retail Distributors industry average as it is not currently profitable.
value
- Symbiox Investment & Trading Co's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Symbiox Investment & Trading Co's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Symbiox Investment & Trading Co is good value based on assets compared to the IN Retail Distributors industry average.
- BSE:539278 is up 8.3% along with the Retail Distributors industry (7.5%) over the past month.
- BSE:539278 is up 8.3% along with the India market (8%) over the past month.
- Symbiox Investment & Trading Co is loss making, we can't compare its value to the IN Retail Distributors industry average.
- Symbiox Investment & Trading Co is loss making, we can't compare the value of its earnings to the India market.
- 539278 underperformed the Retail Distributors industry which returned -12% over the past year.
- 539278 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800